Therapeutic Area Market Research Reports & Industry Analysis
Therapeutic areas include Cardiology/Vascular Diseases, Dental and Oral Health, Dermatology, Devices, Endocrinology, Family Medicine, Gastroenterology, Genetic Disease, Healthy Volunteers, Hematology, Hepatology, Immunology, Infections and Infectious Diseases, Internal Medicine, Musculoskeletal, Nephrology, Neurology, Nutrition and Weight Loss, Obstetrics/Gynecology, Oncology, Ophthalmology, Orthopedics/Orthopedic Surgery, Otolaryngology, Pediatrics/Neonatology, Pharmacology/Toxicology, Podiatry, Psychiatry/Psychology, Pulmonary/Respiratory Diseases, Rheumatology, Sleep, Trauma, Urology, and Vaccines.
Reports in these categories will contain statistics of prevalence and growth concerning therapeutic area diseases for which there are product reviews, market size, and share for products that are used in pharmaceutical treatment or equipment that used in surgical treatment of the therapeutic area.
Therapeutic Area Industry Research & Market Reports
-
Women`s Health Diagnostics
... at a CAGR of 5.8% over the analysis period 2024-2030. Breast Cancer Testing, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$11.3 Billion by the end ... Read More
-
Dilated Cardiomyopathy Therapeutics
... at a CAGR of 4.3% over the analysis period 2024-2030. Angiotensin II Receptor Blockers (ARBs), one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$258.2 Million by ... Read More
-
Rheumatoid Arthritis Therapeutics
... at a CAGR of 4.1% over the analysis period 2024-2030. Pharmaceuticals, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$28.0 Billion by the end of the ... Read More
-
Intrauterine Devices
... CAGR of 3.8% over the analysis period 2024-2030. Hormonal Progestogen-Releasing IUD, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$3.4 Billion by the end of the ... Read More
-
Neuroscience
... 3.9% over the analysis period 2024-2030. Neuroscience Instruments, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$29.9 Billion by the end of the analysis period. Growth ... Read More
-
Pulmonary / Respiratory Drug Delivery
... Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Metered Dose Inhalers, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$35.9 ... Read More
-
Thoracolumbosacral Orthosis (TLSO)
... at a CAGR of 4.7% over the analysis period 2024-2030. The U.S. Market is Estimated at US$584.5 Million While China is Forecast to Grow at 7.2% CAGR The Thoracolumbosacral Orthosis (TLSO) market in the U.S. ... Read More
-
Skin Allergy Therapeutics
... at a CAGR of 5.3% over the analysis period 2024-2030. The U.S. Market is Estimated at US$492.4 Million While China is Forecast to Grow at 8.3% CAGR The Skin Allergy Therapeutics market in the U.S. ... Read More
-
Skin Tightening
... CAGR of 6.2% over the analysis period 2024-2030. Radio Frequency Skin Tightening, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$3.3 Billion by the end of ... Read More
-
Pregnancy and Fertility Testing Products
... Billion by 2030, growing at a CAGR of 6.6% over the analysis period 2024-2030. The U.S. Market is Estimated at US$2.3 Billion While China is Forecast to Grow at 10.7% CAGR The Pregnancy and Fertility ... Read More
-
Artificial Joints
... CAGR of 4.4% over the analysis period 2024-2030. Cemented Joints, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$21.2 Billion by the end of the analysis ... Read More
-
Atopic Dermatitis Drugs
... at a CAGR of 21.1% over the analysis period 2024-2030. Biologics Drug Class, one of the segments analyzed in the report, is expected to record a 22.7% CAGR and reach US$18.7 Billion by the end ... Read More
-
Breast Lesion Localization
... at a CAGR of 4.5% over the analysis period 2024-2030. Breast Biopsy, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$309.2 Million by the end of ... Read More
-
Cancer Diagnostics
... CAGR of 5.8% over the analysis period 2024-2030. Imaging, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$95.3 Billion by the end of the analysis period. ... Read More
-
Anticoagulants
... 9.2% over the analysis period 2024-2030. NOACs, one of the segments analyzed in the report, is expected to record a 10.8% CAGR and reach US$33.4 Billion by the end of the analysis period. Growth in ... Read More
-
Alopecia Drugs
... CAGR of 5.5% over the analysis period 2024-2030. Topical Drugs, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$8.4 Billion by the end of the analysis ... Read More
-
Artificial Saliva
... CAGR of 13.5% over the analysis period 2024-2030. Oral Sprays, one of the segments analyzed in the report, is expected to record a 14.3% CAGR and reach US$1.3 Billion by the end of the analysis ... Read More
-
Bovine Respiratory Disease Treatment
... 2030, growing at a CAGR of 6.4% over the analysis period 2024-2030. Vaccines, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$1.4 Billion by the end ... Read More
-
Cervical Pillows
... CAGR of 5.4% over the analysis period 2024-2030. Standard Pillows, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$2.8 Billion by the end of the analysis ... Read More
-
Sexual Enhancers
... CAGR of 7.7% over the analysis period 2024-2030. Male Sexual Enhancers, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$354.9 Million by the end of the ... Read More
-
Antidepressants
... 2.5% over the analysis period 2024-2030. Major Depressive Disorder, one of the segments analyzed in the report, is expected to record a 2.2% CAGR and reach US$7.0 Billion by the end of the analysis period. ... Read More
-
Infertility Drugs
... CAGR of 5.2% over the analysis period 2024-2030. Hormone-Based Therapy, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$5.3 Billion by the end of the analysis ... Read More
-
Intraoral Scanners
... CAGR of 7.2% over the analysis period 2024-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$507.3 Million by the end of the analysis ... Read More
-
Invisible Orthodontics
... CAGR of 9.2% over the analysis period 2024-2030. Clear Aligners, one of the segments analyzed in the report, is expected to record a 9.9% CAGR and reach US$5.5 Billion by the end of the analysis ... Read More
-
In-Vitro Fertilization
... CAGR of 8.0% over the analysis period 2024-2030. In-Vitro Fertilization Equipment, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$684.2 Million by the end of the ... Read More
Research Assistance
